Shingen Misaka
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Tea Polyphenols and Effects 15
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 11
- Inflammatory mediators and NSAID effects 5
- Co-authors
- Shizuo Yamada (19 shared papers)Satomi Onoue (18 shared papers)Martin F. Fromm (7 shared papers)Fabian Müller (5 shared papers)Junko Kimura (11 shared papers)José Pablo Werba (6 shared papers)Hiroshi Watanabe (9 shared papers)Hartmut Glaeser (3 shared papers)
In The Last Decade
Shingen Misaka
44 papers receiving 965 citations
Peers
Comparison fields: 5 of 96
- Pharmacology 211
- Biological Psychiatry 57
- Pathology and Forensic Medicine 272
- Biochemistry 77
- Complementary and alternative medicine 83
Countries citing papers authored by Shingen Misaka
This map shows the geographic impact of Shingen Misaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingen Misaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingen Misaka more than expected).
Fields of papers citing papers by Shingen Misaka
This network shows the impact of papers produced by Shingen Misaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingen Misaka. The network helps show where Shingen Misaka may publish in the future.
Co-authors
The 25 scholars most cited alongside Shingen Misaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 110 | |
| 2 | 2012 | 82 | |
| 3 | 2015 | 78 | |
| 4 | 2018 | 47 | |
| 5 | 2018 | 47 | |
| 6 | 2008 | 41 | |
| 7 | 2015 | 40 | |
| 8 | 2013 | 39 | |
| 9 | 2010 | 34 | |
| 10 | 2012 | 31 | |
| 11 | 2009 | 29 | |
| 12 | 2009 | 28 | |
| 13 | 2013 | 27 | |
| 14 | 2013 | 26 | |
| 15 | 2013 | 26 | |
| 16 | 2014 | 22 | |
| 17 | 2009 | 21 | |
| 18 | 2015 | 20 | |
| 19 | 2011 | 20 | |
| 20 | 2020 | 19 |
About Shingen Misaka
Shingen Misaka is a scholar working on Pathology and Forensic Medicine, Pharmacology, Oncology, Pharmacology and Cellular and Molecular Neuroscience, having authored 48 papers that have together received 985 indexed citations. Recurring topics across this work include Tea Polyphenols and Effects (15 papers), Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers), Neuropeptides and Animal Physiology (6 papers), Inflammatory mediators and NSAID effects (5 papers), Asthma and respiratory diseases (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Pharmacology (211 citations), Biological Psychiatry (57 citations), Pathology and Forensic Medicine (272 citations), Biochemistry (77 citations) and Complementary and alternative medicine (83 citations). Shingen Misaka has collaborated with scholars based in Japan, Germany and Italy. Frequent co-authors include Shizuo Yamada, Satomi Onoue, Martin F. Fromm, Fabian Müller, Junko Kimura, José Pablo Werba, Hiroshi Watanabe, Hartmut Glaeser, Kenju Shimomura and Hideyuki Sato. Their work appears in journals such as Drug Metabolism and Pharmacokinetics, Clinical Therapeutics, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.